Skip to content
Open access

Inflammatory profiling in ANOCA: IL-6 predicts cardiovascular events independent of coronary microvascular dysfunction

Oct 2026 · European Heart Journal · 0 citations

Abstract

Women with angina and no obstructive coronary artery disease (ANOCA) remain at increased cardiovascular risk, likely in part driven by systemic inflammation and coronary microvascular dysfunction (CMD). Interleukin-6 (IL-6) is a key inflammatory mediator associated with cardiovascular events in the general population and with CMD in women with ANOCA. We aimed to investigate whether IL-6 identifies a cardiometabolic high-risk phenotype and whether IL-6 predicts long-term cardiovascular prognosis in women with ANOCA, more on whether its prognostic value is influenced by CMD. We studied 1,636 women with stable angina and <50% coronary stenosis from the iPOWER (Improving Diagnosis and Treatment of Women with Angina Pectoris and Microvascular Disease) cohort. Key exclusion criteria in the iPOWER cohort were suspected non-ischemic chest pain, reduced left ventricular ejection fraction (<45%), prior myocardial infarction or coronary revascularization and severe comorbidity. Plasma IL-6 was measured at baseline. The primary outcomes was a composite of cardiovascular death, myocardial infarction, revascularization, ischemic stroke, and heart failure. Associations with outcome were assessed using Fine-Gray sub distribution hazard model including non-cardiovascular death as a competing risk adjusted for age and cardiovascular risk factors. Prespecified subgroup analyses included assessment of potential effect modification by CMD defined as coronary flow velocity reserve (CFVR) <2.0. Higher IL-6 was associated with a cardiometabolically shifted phenotype characterized by adiposity, diabetes, a high triglyceride–low HDL-C lipid profile and reduced CFVR. During a median follow-up of 10.8 years, 250 women (15.3%) experienced major adverse cardiovascular events (MACE). Doubling in IL-6 was associated with increased risk of MACE (subdistribution hazard ratio (SHR) 1.19, 95% confidence interval (CI): 1.03-1.37). The association was independent of CMD (unadjusted SHR: 1.30 vs 1.27). IL-6 identified an inflammation-driven cardiometabolic high-risk phenotype in women with ANOCA and independently predicted major adverse cardiovascular events. Its prognostic value was not explained by CMD, underscoring IL-6 as a clinically relevant marker of long-term cardiovascular risk.HeatMap Inflammatory Profiling Women wANOCASmooth HR and density IL-6 and risk of MACE

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.